This group found that knockout of the Rad52 gene in an in vivo ATM−/− mouse model led to not only an increased latency period to develop T-cell lymphoma, but also an increased lifespan and decreased overall tumor incidence in Rad52 knockout mice compared to Rad52 wildtype [33]. Here, RAD52 is linked to T-cell non-Hodgkin lymphoma.